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Quality of valve prostheses. Are we treating our
patients well in the Brazilian National Health
System?
The correction surgery of acquired valvular heart
disease is responsible for about 30% of all cardiac
operations performed in Brazil and the valve prostheses
implantation corresponds to 17.4% of high complexity
surgeries using 25% of government resources for the
cardiovascular field.
The Unified Health System (SUS) (acronym in Portuguese),
accounts for 75% of patients requiring cardiovascular surgery
procedures in Brazil, which provides nationally manufactured
bioprosheses for the surgical treatment of these patients,
represented by the world’s most widely used models with
extensive evidence of effectiveness and quality. However, due
the shortage of studies, there is a lack of data about the
efficiency and durability of bioprostheses in comparison with
the imported bioprostheses, raising questions about the
product quality that SUS provides for the treatment of patients
with valvular heart disease.
The paper written by Almeida et at. [1], published in
this issue (page 326), offers the opportunity to assess the
performance of biological prostheses provided SUS and
ensure the quality of surgical treatment we are offering to
our patients.
A total of 301 patients evaluated in a 20-year follow-up
period, the study compared the results between national
bioprostheses and mechanical prostheses outcomes in
mortality, hemorrhagic events and reoperations in patients
undergoing surgery for aortic valve replacement by
biological or mechanical substitute in a university hospital
that is a reference center for cardiac surgery.
Data from international literature with the studies carried
out so far, have shown that the type of prosthesis, whether
biological or mechanical, did not determine differences
regarding long-term mortality. It also reveals that bleeding
events were more strongly related to mechanical prostheses
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and reoperation for prosthesis dysfunction more frequently
in patients with biological substitute after a 5-year follow-
up period.
In the study by Adams et al., 5, 10 and 15-year survival
after valve replacement surgery for mechanical substitute
was 83.90%, 75.40% and 60.20%, respectively, and for
biological substitute was 89.30%, 70.40% and 58.40%
respectively, with no statistically significant difference in
survival of patients in both groups (P = 0.939) during the
follow-up period. Thus, the bioprostheses examined in the
study had similar performance to that observed in
international studies that compared the long-term
performance of biological and mechanical prostheses. In
addition to that, during Cox regression multivariate analysis,
the type of prosthesis remained unassociated with the death
outcome (P = 0.556), making the data in this study agree
with the current literature.
As expected and consistent with international studies,
major bleeding events tended to be more frequent in patients
with mechanical substitutes (P = 0.084). In patients with
biological substitute there was a higher probability of
reoperation, especially after the first 10-year follow-up.
As it was a retrospective and observational cohort
study performed in a single center, these data should be
confirmed by randomized controlled trials, which constitute
the top of the hierarchy of scientific evidence guiding our
clinical practice.
Ultimately, from the evidence generated by the new
study, the Brazilian cardiac surgeons can be certain that
they are using valve prosthesis with a long-term
performance comparable to those used throughout the
world, performing a high-quality surgery that definitely
benefits patients with valve disease in the National
Health System.
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